Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations

Clinical Chemistry

Volumn 49, Issue 8, 2003, Pages 1331-1336

  Apple, Fred S ^a,b   Quist, Heidi E ^a   Doyle, Patrick J ^a   Otto, Angela P ^a   Murakami, MaryAnn M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; HEPARIN; TROPONIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CAUCASIAN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME ASSAY; ETHNIC DIFFERENCE; FEMALE; HEART INFARCTION; HUMAN; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; RACE DIFFERENCE; REFERENCE VALUE; SEX DIFFERENCE;

ADULT; AGED; ANTICOAGULANTS; CONTINENTAL POPULATION GROUPS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HEPARIN; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TROPONIN I; TROPONIN T;

EID: 0041963115     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.8.1331     Document Type: Article

References (25)

1. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-20.
2. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
3. Braunwald E. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. Committee on the Management of Patients with Unstable Angina. J Am Coll Cardiol 2000;36:970-1062.
4. American Heart Association home page. www.americanheart.org (Accessed November 2002).
5. Scharnhorst V, Vader HL, van der Graaf F. Characteristics of the cardiac troponin I assay on the Immulite 2000 analyzer. Clin Chem 2002;48:1626-7.
6. Uettwiller-Geiger D, Wu AHB, Apple FS, Jevans AW, Venge P, Olson MD, et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002;48:869-76.
7. Sasse EA. How to define and determine reference intervals in the clinical laboratory. NCCLS document C28-A, 2nd ed. Wayne, PA: NCCLS, 2002.
8. Gerhardt W, Nordin G, Herbert AK, Gustavsson E, Muller-Bardorff M, Katus HA. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phase of myocardial injury. Clin Chem 2000;46: 817-21.
9. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AHB. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:174-8.
10. Apple FS, Wu AHB. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001;47:377-9.
11. Apple FS, Wu AHB, Jaffe AS. Implementation of the ESC/ACC guidelines for redefinition of myocardial infarction using cardiac troponin assays with special attention to clinical trial issues. Am Heart J 2002;144:981-6.
12. Koukkunen H, Penttila K, Kemppainen A, Penttila I, Halinen MO, Rantanen T, et al. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol 2001;88:727-31.
13. Meier MA, Al-Badr WH, Cooper JV, Klin-Rogers EM, Smith DE, Eagle KA, et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002;162:1585-9.
14. Apple FS, Johari V, Hoybook KJ, Weber-Shrikant E, Davis GK, Murakami MM. Operationalizing cardiac troponin I testing along ESC/ACC consensus guidelines for defining myocardial infarction: increasing rate of detection. Clin Chim Acta 2003;331:165-6.
15. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, DiPasquele G, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140:917-27.
16. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Tilatky MA. The prognostic value of troponin in patients with non-St elevation acute coronary syndromes: a meta analysis. J Am Coll Cardiol 2001;38:478-85.
17. Apple FS, Murakami MM, Panteghini M, Christenson R, Dati F, Mair J, et al. International survey of cardiac troponin users. Clin Chem 2001;47:587-9.
18. College of American Pathologists. Cardiac marker CAR-C survey participant summary report. Northfield, IL: CAP, 2002:1-30.
19. Lindahl B, Diderholm E, Lagerquist B, Venge P, Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. FRISC II Investigatots. J Am Coll Cardiol 2001;38:979-86.
20. Venge P, Lagerquist B, Diderholm E, Lindahl B, Wallentin L. Clinical performance of three cardiac troponin assays in patient with unstable coronary artery disease. FRISC II Study Group. Am J Cardiol 2002;89:1035-41.
21. Apple FS. Tissue specificity of cardiac troponin I, cardiac troponin T, and creatine kinase MB. Clin Chim Acta 1999;284:151-9.
22. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem 2001;38:423-49.
23. Stiegler H, Fischer Y, Vazquez-Jimenez JF, Graf F, Filzmaier K, Fausten B, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000;46:1338-44.
24. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw NM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1999;45:1104-21.
25. Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement of cardiac troponin in serum. Clin Chem Lab Med 1999;37:1091-5.